Viridian Therapeutics, Inc.\DE (VRDN) Net Income (2016 - 2025)
Historic Net Income for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to -$35.1 million.
- Viridian Therapeutics, Inc.\DE's Net Income rose 5417.68% to -$35.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$302.5 million, marking a year-over-year decrease of 1774.81%. This contributed to the annual value of -$269.9 million for FY2024, which is 1355.09% down from last year.
- According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Net Income is -$35.1 million, which was up 5417.68% from -$100.7 million recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Net Income ranged from a high of -$14.0 million in Q3 2021 and a low of -$100.7 million during Q2 2025
- Its 5-year average for Net Income is -$49.5 million, with a median of -$47.7 million in 2023.
- Data for Viridian Therapeutics, Inc.\DE's Net Income shows a peak YoY increase of 6811.34% (in 2021) and a maximum YoY decrease of 17773.65% (in 2021) over the last 5 years.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Net Income (Quarter) stood at -$28.9 million in 2021, then crashed by 58.17% to -$45.8 million in 2022, then tumbled by 46.03% to -$66.9 million in 2023, then decreased by 19.33% to -$79.8 million in 2024, then surged by 56.07% to -$35.1 million in 2025.
- Its last three reported values are -$35.1 million in Q3 2025, -$100.7 million for Q2 2025, and -$86.9 million during Q1 2025.